Search research articles
Contact Us
Filters
Showing results (771-780 of 774) with videos related to
Page
of 78
Sort By:
You have reached the last page of results.
This site can display upto 774 results.
Proceedings of the National Academy of Sciences of the United States of America
|
April 25, 2023
Identification of small-molecule protein-protein interaction inhibitors for NKG2D
Aaron A Thompson, Michael B Harbut, Pei-Pei Kung, et al.
Nature
|
June 19, 2010
Size and albedo of Kuiper belt object 55636 from a stellar occultation
J L Elliot, M J Person, C A Zuluaga, et al.
Journal of Medicinal Chemistry
|
February 3, 2017
Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
Philip A Harris, Scott B Berger, Jae U Jeong, et al.
Journal of Medicinal Chemistry
|
April 24, 2019
Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase
Philip A Harris, Nicolas Faucher, Nicolas George, et al.
Page
of 78
Search research articles
Search
Showing results (771-780 of 774) with videos related to
Sort By:
Page
of 78
You have reached the last page of results.
This site can display upto 774 results.
Proceedings of the National Academy of Sciences of the United States of America
|
April 25, 2023
Identification of small-molecule protein-protein interaction inhibitors for NKG2D
Aaron A Thompson, Michael B Harbut, Pei-Pei Kung, et al.
Nature
|
June 19, 2010
Size and albedo of Kuiper belt object 55636 from a stellar occultation
J L Elliot, M J Person, C A Zuluaga, et al.
Journal of Medicinal Chemistry
|
February 3, 2017
Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
Philip A Harris, Scott B Berger, Jae U Jeong, et al.
Journal of Medicinal Chemistry
|
April 24, 2019
Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase
Philip A Harris, Nicolas Faucher, Nicolas George, et al.
Page
of 78